Advertisement

Topics

Cutaneous Abscess - Biotech, Pharma and Life Science Channel

23:29 EDT 16th August 2018 | BioPortfolio

PubMed Articles [1146 Associated PubMed Articles listed on BioPortfolio]

Transcanal incision and drainage of a parapharyngeal abscess in a pediatric patient: A novel technique.

The disease of parapharyngeal abscess is well known to the otolaryngologist and is commonly managed via transoral, transcervical, or combined incision and drainage. We report a novel approach to an ab...

The Fas Signaling Pathway Is a Common Genetic Risk Factor for Severe Cutaneous Drug Adverse Reactions Across Diverse Drugs.

Human leukocyte antigen (HLA) has been recognized as the most important genetic risk factor for severe cutaneous adverse drug reactions (SCARs) caused by certain drugs. However, cumulated observations...

A CASE OF PROPYLTHIOURACIL (PTU) INDUCED ANTINEUTROPHIL CYTOPLASMIC ANTIBODY (ANCA) POSITIVE CUTANEOUS VASCULITIS IN A HISPANIC WOMAN.

Mapping, in vivo, the uniformity of two skin properties alongside the human face by a 3D virtual approach.

To determine the homogeneity in the distribution of two cutaneous functions (hydration and elasticity) along the entire human face.

Cutaneous anaesthesia of hip surgery incisions with iliohypogastric and subcostal nerve blockade: A randomised trial.

Cutaneous nerve blockade may improve analgesia after hip surgery. Anaesthesia after the lateral femoral cutaneous (LFC) nerve block is too distal for complete coverage of most hip surgery incisions, w...

Macrophage-derived LTB4 promotes abscess formation and clearance of Staphylococcus aureus skin infection in mice.

The early events that shape the innate immune response to restrain pathogens during skin infections remain elusive. Methicillin-resistant Staphylococcus aureus (MRSA) infection engages phagocyte chemo...

Effects and Mechanism of Nicotinamide Against UVA- and/or UVB-mediated DNA Damages in Normal Melanocytes.

Melanoma incidences are increasing rapidly, and ultraviolet (UV) radiation from the sun is believed to be its major contributing factor. UV exposure causes DNA damage in skin which may initiate cutane...

PUVA and interferon-α2b combined therapy for patients with mycosis fungoides at different stages of the disease: a seven-year retrospective study in Russia.

Mycosis fungoides (MF) is a clinical-pathologically heterogeneous group of Cutaneous T-Cell Lymphomas (CTCLs) primarily developing and affecting the skin. PUVA is the gold standard of treatment in ear...

Reply to: "S2k guideline for treatment of cutaneous lupus erythematosus - guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV)".

We read with great interest the guideline for the treatment of cutaneous lupus erythematosus (CLE) elaborated by the European Dermatology Forum in cooperation with the European Academy of Dermatology ...

Reply to the letter by Pindado-Ortega et al.

We thank Pindado-Ortega and colleagues for their valuable comments on the use of pulsed-dye laser (PDL) on active lesions of cutaneous lupus erythematosus (CLE) (1). The effectiveness of PDL has been ...

News Articles [125 Associated News Articles listed on BioPortfolio]

Lancet publishes PhIII data on Kyowa Hakko’s Poteligeo

The Lancet has published data from Kyowa Hakko Kirin Co’s successful Phase III trial of immunotherapy Poteligeo underpinning its recent approval in the US to treat in patients with cutaneous T-c...

Tyrosine Protein Kinase SYK Spleen Tyrosine Kinase or p72 Syk or SYK or EC 2.7.10.2 Pipeline Review, H1 2018 [Report Updated: 22052018] Prices from USD $3500

Tyrosine Protein Kinase SYK Spleen Tyrosine Kinase or p72 Syk or SYK or EC 2.7.10.2 Pipeline Review, H1 2018SummaryTyrosine Protein Kinase SYK Spleen Tyrosine Kinase or p72 Syk or SYK or EC 2.7.10.2 ...

GI Dynamics Announces FDA Approval for EndoBarrier Pivotal Trial

Pivotal trial to focus on reduction of hemoglobin A1c for patients diagnosed with type 2 diabetes and obesity GI Dynamics Inc. (ASX:GID): ...

Control Medical Technology LLC Product Pipeline Analysis, 2018 Update [Report Updated: 30052018] Prices from USD $750

SummaryControl Medical Technology LLC Control Medical is a medical device company that develops designs and markets aspirator products. The company offers aspiration with a handheld handoperated devic...

Tyrosine Protein Kinase JAK1 Janus Kinase 1 or JAK1 or EC 2.7.10.2 Pipeline Review, H1 2018 [Report Updated: 22052018] Prices from USD $3500

Tyrosine Protein Kinase JAK1 Janus Kinase 1 or JAK1 or EC 2.7.10.2 Pipeline Review, H1 2018SummaryTyrosine Protein Kinase JAK1 Janus Kinase 1 or JAK1 or EC 2.7.10.2 pipeline Target constitutes close ...

Kyowa Kirin Announces FDA Approval of Poteligeo® (mogamulizumab-kpkc) for the Treatment of Mycosis Fungoides and Sézary Syndrome

Tokyo (ots/PRNewswire) - - Poteligeo has been approved for the treatment of the two most common types of Cutaneous T-cell lymphoma (CTCL) in previously treated patients based on data showing improv...

Kyowa Kirin Announces FDA Approval of Poteligeo (mogamulizumab-kpkc) for the Treatment of Mycosis Fungoides and Sézary Syndrome

TOKYO, August 8, 2018 /PRNewswire/ -- Poteligeo has been approved for the treatment of the two most common types of Cutaneous T-cell lymphoma (CTCL) in previously treated patients based on data sh...

FDA Approves Mogamulizumab for CTCL

The FDA has approved mogamulizumab for the treatment of patients with cutaneous T-cell lymphoma who have received at least 1 prior systemic therapy.

FDA Approves New Drug for Cutaneous T-Cell Lymphomas

The FDA has granted approval for mogamulizumab-kpkc for adult patients with relapsed or refractory mycosis fungoides or Sézary syndrome. FDA Approvals

Anti-CCR4 Agent Gets FDA Thumbs Up for Cutaneous Lymphomas

(MedPage Today) -- First drug approved specifically for rare Sézary syndrome

Events [0 Results]

None

Companies [10 Associated Companies listed on BioPortfolio]

Castle Biosciences, Inc.

Castle Biosciences is a molecular diagnostics and prognostics company dedicated to helping patients and their physicians make the best possible decisions about their treatment and...

Ralexar Therapeutics, Inc.

Ralexar Therapeutics, Inc. is a privately-held specialty pharmaceutical company founded in January 2014 and based in Malvern, Pennsylvania. The company is developing topical and s...

Stemedica Cell Technologies Inc.

Stemedica Cell Technologies Inc. is a specialty biopharmaceutical company that is committed to the manufacturing and development of best-in-class, allogeneic, adult stem cells and...

Shape Pharmaceuticals, Inc.

Shape Pharmaceuticals, Inc. is developing SHP-141, a novel, topical, “soft-drug” HDAC inhibitor for the treatment of patients with cutaneous T cell lymphoma (CTCL) and p...

Ceptaris Therapeutics, Inc.

Ceptaris Therapeutics, Inc. is a privately held, specialty pharmaceutical company that is developing a proprietary gel formulation of mechlorethamine hydrochloride for the treatme...

fOCUS Pharmaceuticals, LLC

fOCUS Pharmaceuticals is a privately held generic and branded pharmaceutical company specializing in the research and development of prescription dermatology products. Our primary focus are in the are...

Gloucester Pharmaceuticals

Gloucester Pharmaceuticals acquires clinical-stage oncology drug candidates and advances them through regulatory approval and commercialization. The Company’s first candidate...

BioCryst Pharmaceuticals, Inc.

BioCryst Pharmaceuticals designs, optimizes and develops novel small-molecule pharmaceuticals that block key enzymes involved in infectious diseases, cancer and inflammatory disea...

Yaupon Therapeutics, Inc.

Yaupon Therapeutics, a privately held, specialty pharmaceutical company, is developing a proprietary gel formulation of mechlorethamine hydrochloride for the treatment of early st...

Celtaxsys, Inc.

Celtaxsys is privately-held start-up focused on discovery and development of therapeutics to treat inflammation. The Company has identified a portfolio of immunoregulators that redirect immune cell mi...

Clinical Trials [628 Associated Clinical Trials listed on BioPortfolio]

Safety, Tolerability, Immunogenicity, and Antitumor Activity of GEN-009 Adjuvanted Vaccine

In this study, Genocea is evaluating an investigational, personalized adjuvanted vaccine, GEN-009, that is being developed for the treatment of patients with solid tumors. A proprietary to...

Confirmatory Trial in the Evaluation of Ca Electroporation for the Treatment of Cutaneous Metastases

Electroporation is a method that can facilitate transport of molecules across the cell membrane and into the cell by means of electrical pulses. The method can be used with molecules that ...

Adaptation of the Questionnaire "Regarding Patient's Quality of Life With Mastocytosis" in the French Language

Mastocytosis is a heterogeneous rare disease. A 27-item questionnaire to assess the quality of life of patients with cutaneous/ indolent systemic mastocytosis was developed in the German l...

Mirror Therapy With Cutaneous Electrical Sensory Stimulation on Lower Limb Motor Functions in Stroke

This study aims to evaluate the effectiveness of concurrent mirror therapy (MT) and transcutaneous electrical nerve stimulation (TENS) in augmenting the efficacy of the lower limb task-ori...

Clinical Aspect of Erosive Pustular Dermatosis of the Leg

Erosive pustular dermatosis of the leg is a fairlyrecent clinical entity that was described the first time in 1987. Diagnosis of erosive pustular dermatosis of the leg is made on clinical...

Anatomical Study of the Arteries of the Skin on Amputation Legs

PRIMARY OBJECTIVE Qualitatively describe the distribution of cutaneous arteries in patients with long-term occlusive arterial disease. SECONDARY OBJECTIVE To compare the distribution of c...

Pembrolizumab and Total Skin Electron Beam Radiotherapy in Mycosis Fungoides and Sézary Syndrome

Hypothesis: Addition of low dose TSEBT to debulk MF/SS either before or during checkpoint blockade with anti-PD-1 pembrolizumab monoclonal antibody therapy will be safe and well tolerated....

Efficacy of the Cosmetic Product "Onco-Repair" on Grade 2 Hand Foot Syndrome

The aim of the study is to assess the restorative efficacy of the cosmetic product "Onco-Repair" vs placebo of the most affected palmer face in subject with grade 2 HFS induced by targeted...

Thyroid Dysfunction in Female Patients With Acne Vulgaris: [ Relation to Other Variables ]

Acne is a chronic inflammatory disease of the pilo-sebaceous unit with a multi-factorial etiology. It is one of the most frequent cutaneous diseases, affecting more than eighty percent of ...

Pacritinib in Relapsed/Refractory Lymphoproliferative Disorders

This trial will determine the safety and tolerability of Pacritinib in patients with relapsed/refractory lymphoproliferative disorders.

Videos

None available.

Medical and Biotech [MESH] Definitions

Accumulation of purulent EXUDATES beneath the DIAPHRAGM, also known as upper abdominal abscess. It is usually associated with PERITONITIS or postoperative infections.

A parasitic hemoflagellate of the subgenus Leishmania leishmania that infects man and animals including rodents. The Leishmania mexicana complex causes both cutaneous (LEISHMANIASIS, CUTANEOUS) and diffuse cutaneous leishmaniasis (LEISHMANIASIS, DIFFUSE CUTANEOUS) and includes the subspecies amazonensis, garnhami, mexicana, pifanoi, and venezuelensis. L. m. mexicana causes chiclero ulcer, a form of cutaneous leishmaniasis (LEISHMANIASIS, CUTANEOUS) in the New World. The sandfly, Lutzomyia, appears to be the vector.

Abscess of the PSOAS MUSCLES resulting usually from disease of the lumbar vertebrae, with the pus descending into the muscle sheath. The infection is most commonly tuberculous or staphylococcal.

A disease caused by any of a number of species of protozoa in the genus LEISHMANIA. There are four major clinical types of this infection: cutaneous (Old and New World) (LEISHMANIASIS, CUTANEOUS), diffuse cutaneous (LEISHMANIASIS, DIFFUSE CUTANEOUS), mucocutaneous (LEISHMANIASIS, MUCOCUTANEOUS), and visceral (LEISHMANIASIS, VISCERAL).

An abscess located in the abdominal cavity, i.e., the cavity between the diaphragm above and the pelvis below. (From Dorland, 27th ed)

Advertisement
Quick Search
Advertisement
Advertisement

 
review and buy Cutaneous Abscess market research data and corporate reports here

Channels Quicklinks